NHAI has enough cash to speed up road building: Gadkari at NCD listing event

Gadkari while speaking at the listing ceremony of the National Highways Infra Trust's non-convertible debentures called the NHAI a gold and said that there is no shortfall of funds for infrastructure development in India.

Moneycontrol News

October 28, 2022 / 10:36 IST

Union Minister Nitin Gadkari

Union Minister for Roads and Highways Nitin Gadkari has assured investors that the National Highways Authority of India has enough funds to increase the pace of road building.

Speaking at the listing ceremony of the National Highways Infra Trust's non-convertible debentures, he referred to the NHAI as gold and said that there is no shortfall of funds for infrastructure development in India.

Gadkari's statement comes when the pace of road construction has fallen to nearly 17 km a day in India, when the government is aiming to build 40 km of roadways a day.

The minister also said that the government will soon come out with investment opportunities for retail investors in road infrastructure projects, where investors will also be allowed to collect returns on a monthly basis.

NHAI Chairman Alka Upadhyaya also said that the NHAI has gained confidence after the first round of asset monetisation of roads and is optimistic about the second round of asset monetisation from the road segment.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show